NEW YORK (GenomeWeb News) — In an intellectual property lawsuit brought against Roche by Cepheid, a federal court has ordered that a hearing be delayed on whether a PCR patent owned by Roche is invalid and expired until an outcome is achieved in arbitration proceedings between the companies.

The court also has dismissed additional counts by Cepheid against Roche seeking judgment that a second PCR patent owned by Roche is unenforceable, citing a lack of subject matter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.